vial and syringe

DEVICE2 trials

Sponsors

Novo Nordisk A/S, Astria Therapeutics, Inc.

Conditions

Delivery SystemsDiabetesDiabetes Mellitus, Type 2Healthy Adult Participants

Phase 1

Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe

CompletedNCT00127296

Novo Nordisk A/SDelivery Systems, Diabetes, Diabetes Mellitus, Type 2

Start: 2005-07-31End: 2005-09-30Updated: 2017-01-06

A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants

RecruitingNCT07635095

Astria Therapeutics, Inc.Healthy Adult Participants

Start: 2026-04-21End: 2026-12-01Target: 180Updated: 2026-06-09